Figure 2.

Vascular dysfunction in DRS patients treated with nystatin. Vascular endothelium-dependent flow-mediated dilatation (A) and endothelium-independent nitroglycerine-mediated dilatation (B) parameters were assessed by ultrasonography before starting nystatin therapy, immediately after finishing it and 2 months after therapy completion

Results presented as median (box: Q1–Q3; whisker: minimal and maximal measurements). ^#p < 0.05 for comparison of 2^nd and 3^rd visit; ^¶p < 0.05 for comparison of 1^st and 3^rd visit.